Protagenic Therapeutics Inc. has disclosed a delay in filing its Form 10-Q for the quarter ended September 30, 2025. This reporting delay was cited as one of the reasons the company received a Nasdaq non-compliance notice.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Protagenic Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-025159), on November 26, 2025, and is solely responsible for the information contained therein.
Comments